Skip to Content

Dear Lunit INSIGHT users

Lunit INSIGHT has been updated for your better user experience.

Greeting from Lunit

It is already 22nd day of January, we wish you belated happy new year!

Last year at RSNA, we appreciate your attention and interest in Lunit INSIGHT public launch.

Currently users from 35 and more countries with diverse specialty have used Lunit INSIGHT, and we have been able to receive many useful feedback.

Lunit payes attention to each and every one of your opinions, and also, we will continuously update Lunit INSIGHT.




We would like to hare updated features by January 22nd.

  • Stronger de-identification feature
    • Lunit INSIGHT provide de-identification process of all sensitive information from DICOM headers directly at web browser, therefore those sentivie information will not be transferred to server for analysis.
    • In addition, all images uploaded to Lunit INSIGHT are automatically deleted immediately after results are generated.
  • Sample DICOM file providing service
    • For users who wish to experience Lunit INSIGHT but does not have adequate DICOM file, we provide a public data from NIH (National Institutes of Health). Anyone can log in and easily download.

Lunit INSIGHT will continue to apply/reflect user's feedback and improve user experience to its fullest, and also, we will try our best for Lunit INSIGHT to be used in many various environment.

We welcome any kind of comments, including credits and critics. If you have not yet participated in the survey, please click the following survey link and increase the maximum daily analysis allowance from 10 images to 20 images.


Participate in Survey


In 2018, great challenges wait ahead of us.

We will pay attention to all your feedback, and continue moving forward.

Thank you.



From Lunit Team

About Lunit (루닛)

Perfecting Intelligence. Transforming Medicine.

Lunit, abbreviated from “learning unit,” is a medical AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. It has been named by CB Insights as one of “AI 100” startups transforming healthcare industry.

Lunit's technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is based in Seoul, South Korea.

Lunit’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

루닛은 딥러닝 기술을 기반으로 한 의료 AI(인공지능) 기업이다. 2013년 설립된 루닛은 지난해 CB인사이트가 선정한 'AI 100대 스타트업'에 한국 기업으로는 유일하게 이름을 올리며 국제 의료 산업을 변화시키는 선두주자로 자리매김했다.

루닛은 세계 최고 수준의 인공지능 기술을 중심으로 데이터 기반의 이미징 바이오마커(imaging biomarker)를 발견하고 이를 활용해 의사의 진단 및 치료 과정의 정확성과 효율성을 향상시키는 것을 목표로 하고 있다.

Lunit (루닛)
6th floor, 175 Yeoksam-ro, Gangnam-gu,
Seoul, South Korea

서울시 강남구 역삼로 175 6층 (역삼동, 현승빌딩)